Arda Therapeutics
Arda Therapeutics develops targeted cell depletion therapies for chronic diseases. Their approach focuses on eliminating disease-driving cells, rather than modulating protein activity, aiming for greater efficacy and fewer side effects than conventional treatments. This innovative strategy uses a sophisticated single-cell-based discovery engine to identify and target pathogenic cells with precision.
Buy Funded Startups lists
Funding Round: Series A
Funding Amount: $43M
Date: 09-Oct-2024
Investors: Andreessen Horowitz (a16z Bio + Health), Two Sigma Ventures, RV Invest, Eli Lilly and Company, GV, Biovision Ventures, Valhalla Ventures, Indicator Ventures, Alumni Ventures, LifeLink Ventures, Mana Ventures, Gaingels, ExitFund
Markets: Biotechnology, Healthtech, Therapeutics
HQ: San Francisco, California, United States
Founded: 2021
Website: https://www.ardatx.com
LinkedIn: https://www.linkedin.com/company/arda-therapeutics
Twitter: https://twitter.com/Arda_Tx
Crunchbase: https://www.crunchbase.com/organization/arda-therapeutics
Leave a Comment
Comments
No comments yet.